Alkem Laboratories Ltd v. Rexha Pharmaceuticals Private Limited

4-ial-12636-2025.doc IN THE HIGH COURT OF JUDICATURE AT BOMBAY ORDINARY ORIGINAL CIVIL JURISDICTION IN ITS COMMERCIAL DIVISION COMMERCIAL IP SUIT NO.449 OF 2025 WITH INTERIM APPLICATION (L) NO.12636 OF 2025 WITH LEAVE PETITION (L) NO.12758 OF 2025 VISHAL SUBHASH PAREKAR VISHAL SUBHASH PAREKAR Date: 2025.12.05 14:47:28 +0530 Alkem Laboratories Limited ...Plaintiff

Versus

Rexha Pharmaceuticals Private Limited ...Defendant ------ Mr. Mahesh Mahadgut a/w. Mr. Kaivalya Shetye, for the Plaintiff. Dr. Haris Khan, Director Legal of Defendant Co. present through VC. ------ CORAM : SHARMILA U. DESHMUKH, J.

DATE : DECEMBER 04, 2025 P. C. :

1.

This Court is informed that the suit has been settled between the parties.

2.

The consent terms are tendered which are taken on record and marked X for identification. Consent terms are executed by the legal representative of the Plaintiff and Director of the Defendant. The board resolution is annexed to the consent terms. The legal Director of the Defendant is present virtually and reiterates the terms of the Vishal Parekar 1 of

4-ial-12636-2025.doc consent terms and submit to decree on admission in terms of prayer clause (a) and (b). His identity is verified from the Aadhar card which is placed on record as well as by his counsel.

3.

Suit is decreed in terms of prayer clause (a) and (b). Decree be drawn up accordingly. Refund of Court fees as per rules. 4.

Statement made in the consent terms is accepted as undertaking given to this Court.

5.

Interim Application do not survive for consideration and stands disposed of.

Leave Petition (L) No. 12758 of 2025 6.

As the suit has been settled between the parties, Leave Petition stands disposed of.

[SHARMILA U. DESHMUKH, J.] Vishal Parekar 2 of